Rosenstock J, Wysham C, Frias JP, Kaneko S, Lee CJ, Fernandez Lando L
However, it is essential to evaluate these mechanisms in the context of pharmacological feasibility
The following conditions are contraindications, and a full medical assessment at Trusta Clinic will confirm whether the treatment is appropriate before any prescription is given: Multiple Endocrine Neoplasia Type 2 (MEN-2): A genetic endocrine condition that rules out the use of GLP-1 receptor agonists Personal or family history of Medullary Thyroid Carcinoma (MTC): Due to a theoretical thyroid C-cell risk, shared by all GLP-1 agonists Pregnancy or planned pregnancy: Retatrutide is not suitable during pregnancy Breastfeeding Known hypersensitivity to Retatrutide or any component of the medication Retatrutide vs Other Weight Loss Peptides: How Does It Compare
Developed over 27 years of research and experience, we are committed to delivering the highest quality accredited CME training for medical professionals
From hormone testing to individualized supplement plans, our team helps women in Naples and Collier County feel like themselves again
Known as GLP-1 agonists, the class includes Novo Nordisks Ozempic, Wegovy, Rybelsus and Saxenda, as well as Eli Lillys Trulicity